Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Evolution of DMDD Children and Adolescent

N/AUnknownNCT04820946
Centre Hospitalier Universitaire, Amiens55 enrolled

Overview

Little is known about the natural course and prognosis factors of inpatients and outpatients with Disruptive Mood Dysregulation Disorder (DMDD). The investigators conducted a cross-sectional study to determine the evolution of a sample of DMDD patients referred to the hospital for suicidal behaviors between 2013 and 2018 in terms of diagnostic stability, psychiatric comorbidity, and psychosocial factors. A group of patients with various episodic mood disturbances was used as a clinical case control group. In addition to change in DMDD symptoms across time, the investigators examined the onset and persistence of psychiatric comorbidity using the KIDDIE-SADS PL and suicidal behaviors using the Colombia Suicidality Severity Rating Scale. The investigators also examined the persistence of depressive symptoms using the Beck Depression Inventory (BDI-II), the persistence of emotional lability (Affective Lability Scale-18), borderline traits (Abbreviated Diagnostic of Inventory Borderline). Socio-demographic, clinical features and actigraphy-measured sleep characteristics determined between 2013 and 2018 were used to predict the evolution of the DMDD patients and the clinical control group.

Study Type

OBSERVATIONAL

Enrollment

55

Conditions

Disruptive Mood Dysregulation DisorderPrognosis FactorsSuicidal BehaviorsActigraphy

Eligibility

Sex: ALLMin age: 10 YearsMax age: 25 Years
Medical Language ↔ Plain English
Inclusion Criteria: * Boys and girls between 10 and 25-year-old * patients who had been referred to the university hospital of Amiens for suicidal behaviors between 2013 and 2018 * patients who participated to the study "Clinical and actigraphy-measured profiles of inpatient youths with suicidal behavior: exploration of the severe mood dysregulation" Exclusion Criteria: * No affiliation to a social security service * Persons deprived of their liberty as stipulated in article L.1121-6 of the Public Health Code

Locations (1)

CHU Amiens

Amiens, France

RECRUITING

Outcomes

Primary Outcomes

Diagnostic evolution toward an other psychiatric disorder.

The evolution toward another psychiatric disorder would be examined using the semi-structured interview KIDDIE-SADS and the Ab-DIB to examine borderline traits. The K-SADS is a semi-structured interview to measure current and past symptoms of mood, anxiety, psychotic, and disruptive behavior disorders in children ages 6-18 years old. (Ab-DIB) as a screening measure of borderline psychopathology in an adolescent clinical population.

Time frame: one day

persistence of a full-blown DMDD diagnostic

The persistence of a full-blown DMDD diagnostic would be defined using the DSM-5 criteria. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) is the 2013 update to the Diagnostic and Statistical Manual of Mental Disorders, the taxonomic and diagnostic tool published by the American Psychiatric Association.

Time frame: one day

Central Contacts

Xavier BENAROUS, MD

CONTACT

03.22.08.76.30benarous.xavier@chu-amiens.fr
Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.